EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS

Xianjun Chen iD, Ying Liu, Song Mu, Tingting Chen, Jia Yuan, Chuan Xiao, Qi Dong, Qing Li, Ying Wang, Qimin Chen, Shuwen Li, Wei Li und 1 weitere

The FASEB Journal · 2025

DOI: 10.1096/fj.202502459rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xianjun Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, NF-kappa B, Lipopolysaccharides, Signal Transduction. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Guizhou Provincial Health and Wellness Commission Science and Technology Fund Project, The Cultivate project 2024 for National Natural Science Foundation of China, the Affiliated Hospital of Guizhou Medical University, Guizhou Medical University Affiliated Hospital Doctoral Initiation Grant Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alveolar hypercoagulation and fibrinolytic inhibition are key drivers of refractory hypoxemia in acute respiratory distress syndrome (ARDS). Orosomucoid 1 (ORM1), associated with coagulation and the NF‐κB pathway, is hypothesized to regulate these processes in ARDS via NF‐κB. By using LPS‐induced ARDS rats and alveolar epithelial type II (AEC II) cells, we measured ORM1 expression and its effects on tissue factor (TF) and plasminogen activator inhibitor‐1 (PAI‐1). NF‐κB pathway involvement was assessed. Clinically, bronchoalveolar lavage fluid (BALF) ORM1 levels and their correlation with TF/PAI‐1 were analyzed in ARDS patients. In ARDS rats, ORM1 was upregulated in lung tissue and BALF, correlating with increased TF, PAI‐1, and type III collagen. In vitro, ORM1 promoted TF and PAI‐1 expression in LPS‐stimulated AEC II cells. These effects were mediated through the NF‐κB pathway. Clinically, BALF ORM1 levels were elevated in ARDS patients and positively correlated with TF and PAI‐1. ORM1 regulates alveolar hypercoagulation and fibrinolytic inhibition in LPS‐induced ARDS via the NF‐κB pathway, identifying it as a promising therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress SyndromeNF-kappa BLipopolysaccharidesSignal TransductionFibrinolysisOrosomucoidPulmonary AlveoliThrombophiliaAnimalsRatsHumansMalePlasminogen Activator Inhibitor 1Rats, Sprague-DawleyFemaleMiddle AgedThromboplastinBronchoalveolar Lavage FluidAlveolar Epithelial Cells

Stichwörter der Autor:innen

NF‐κB signaling pathwayOrosomucoid 1 (ORM1)acute respiratory distress syndrome (ARDS)alveolar hypercoagulationfibrinolytic inhibition

Substanzen

NF-kappa BLipopolysaccharidesOrosomucoidPlasminogen Activator Inhibitor 1Thromboplastin

Autor:innen und Institutionen

  • Department of Intensive Care Unit, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Respiratory and Critical Care Medicine, Wuhan No. 1 Hospital, Wuhan, Hubei, China.
  • Department of Anorectal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Clinical Medicine, Xi'an Medical College, Xi'an, Shaanxi, China.

ORCID-Profile: Xianjun Chen, Feng Shen

Förderung

  • The Guizhou Provincial Health and Wellness Commission Science and Technology Fund Project
  • The Cultivate project 2024 for National Natural Science Foundation of China, the Affiliated Hospital of Guizhou Medical University
  • Guizhou Medical University Affiliated Hospital Doctoral Initiation Grant Program
  • National Natural Science Foundation of China
  • 2021 In-Hospital Clinical Research Project of the Affiliated Hospital of Guizhou Medical University

Zitieren

APA

Chen, X., Liu, Y., Mu, S., Chen, T., Yuan, J., Xiao, C., Dong, Q., Li, Q., Wang, Y., Chen, Q., Li, S., Li, W., & Shen, F. (2025). Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS. The FASEB Journal. https://doi.org/10.1096/fj.202502459rr

Vancouver

Chen X, Liu Y, Mu S, Chen T, Yuan J, Xiao C, et al. Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS. The FASEB Journal. 2025. doi:10.1096/fj.202502459rr

BibTeX
@article{Chen2025,
  author = {Chen, Xianjun and Liu, Ying and Mu, Song and Chen, Tingting and Yuan, Jia and Xiao, Chuan and Dong, Qi and Li, Qing and Wang, Ying and Chen, Qimin and Li, Shuwen and Li, Wei and Shen, Feng},
  title = {Orosomucoid 1 Participates in Alveolar Hypercoagulation and Fibrinolytic Inhibition Involving NF ‐ κB Signaling Pathway in LPS ‐Induced ARDS},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502459rr}
}
Kostenlos starten →